Personal tools

Coexpression cluster:C3295

From FANTOM5_SSTAR

Revision as of 16:03, 26 November 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C3295_myeloma_lymphangiectasia_CD4_adult_mycosis_CD8_hereditary



Phase1 CAGE Peaks

Hg19::chr12:53601025..53601043,-p1@ITGB7
Hg19::chr12:53601055..53601073,-p2@ITGB7
Hg19::chr12:9823796..9823803,-p@chr12:9823796..9823803
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen
hematopoietic stem cell1.03e-80168
angioblastic mesenchymal cell1.03e-80168
hematopoietic oligopotent progenitor cell1.29e-76161
hematopoietic multipotent progenitor cell1.29e-76161
hematopoietic cell1.42e-74177
leukocyte4.59e-68136
hematopoietic lineage restricted progenitor cell1.02e-60120
nongranular leukocyte1.49e-59115
nucleate cell5.44e-3855
lymphocyte1.61e-3753
common lymphoid progenitor1.61e-3753
lymphoid lineage restricted progenitor cell7.40e-3752
myeloid cell1.81e-36108
common myeloid progenitor1.81e-36108
myeloid leukocyte1.43e-2372
granulocyte monocyte progenitor cell1.65e-2367
myeloid lineage restricted progenitor cell5.40e-2266
macrophage dendritic cell progenitor2.16e-2161
monopoietic cell7.88e-2059
monocyte7.88e-2059
monoblast7.88e-2059
promonocyte7.88e-2059
lymphocyte of B lineage7.37e-1924
pro-B cell7.37e-1924
defensive cell6.92e-1848
phagocyte6.92e-1848
classical monocyte1.55e-1742
CD14-positive, CD16-negative classical monocyte1.55e-1742
T cell2.31e-1625
pro-T cell2.31e-1625
mature alpha-beta T cell7.70e-1618
alpha-beta T cell7.70e-1618
immature T cell7.70e-1618
mature T cell7.70e-1618
immature alpha-beta T cell7.70e-1618
mesenchymal cell2.79e-13354
connective tissue cell3.32e-12361
CD8-positive, alpha-beta T cell1.41e-1011
B cell2.33e-1014
motile cell1.29e-08386
Uber Anatomy
Ontology termp-valuen
hematopoietic system6.80e-3298
blood island6.80e-3298
hemolymphoid system2.13e-29108
immune system1.63e-2293
bone marrow1.43e-2076
bone element1.45e-1782
skeletal element2.87e-1490
skeletal system1.63e-11100
connective tissue2.19e-11371
adult organism4.75e-10114
blood3.89e-0815
haemolymphatic fluid3.89e-0815
organism substance3.89e-0815
Disease
Ontology termp-valuen
hematologic cancer1.94e-1551
immune system cancer1.94e-1551
leukemia1.28e-1139
myeloid leukemia1.54e-1031
lymphoma7.89e-0710


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
IRF4#3662214.60967512449610.006056122473217890.026813149136479
NFKB1#479035.488063424193840.006049381815655430.0268893167962733
ZEB1#6935211.25895467836260.01010222676646330.0378038074192074



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.